1. Home
  2. MRAM vs ALEC Comparison

MRAM vs ALEC Comparison

Compare MRAM & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$9.41

Market Cap

258.7M

Sector

Technology

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$2.06

Market Cap

262.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
ALEC
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
258.7M
262.7M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
MRAM
ALEC
Price
$9.41
$2.06
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$14.00
$4.83
AVG Volume (30 Days)
433.4K
753.5K
Earning Date
03-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,417,000.00
$21,045,000.00
Revenue This Year
$10.87
N/A
Revenue Next Year
$8.33
$45.24
P/E Ratio
N/A
N/A
Revenue Growth
37.51
N/A
52 Week Low
$4.34
$0.87
52 Week High
$17.24
$3.40

Technical Indicators

Market Signals
Indicator
MRAM
ALEC
Relative Strength Index (RSI) 42.11 46.97
Support Level $8.42 $1.82
Resistance Level $9.74 $2.55
Average True Range (ATR) 0.58 0.17
MACD 0.00 -0.03
Stochastic Oscillator 28.25 24.26

Price Performance

Historical Comparison
MRAM
ALEC

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: